BECTON, DICKINSON AND COMPANY (BDX) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 22.48B USD | |
| Cost of products and services | 11.93B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $22.48B | $11.93B | (m) |
| 2026-03-31 | (m) | $22.23B | $11.75B | (m) |
| 2025-12-31 | (m) | $21.92B | $11.82B | (m) |
| 2025-09-30 | (m) | $21.84B | $11.91B | (m) |
| 2025-06-30 | (m) | $21.39B | $11.77B | (m) |
| 2025-03-31 | (m) | $20.87B | $11.58B | (m) |
| 2024-12-31 | (m) | $20.64B | $11.31B | (m) |
| 2024-09-30 | (m) | $20.18B | $11.05B | (m) |
| 2024-06-30 | (m) | $19.83B | $11.49B | (m) |
| 2024-03-31 | (m) | $19.72B | $11.58B | (m) |
| 2023-12-31 | (m) | $19.49B | $11.43B | (m) |
| 2023-09-30 | (m) | $19.37B | $11.20B | (m) |
| 2023-06-30 | (m) | $19.05B | $10.50B | (m) |
| 2023-03-31 | (m) | $18.81B | $10.30B | (m) |
| 2022-12-31 | (m) | $18.74B | $10.35B | (m) |
| 2022-09-30 | (m) | $18.87B | $10.39B | (m) |
| 2022-06-30 | (m) | $20.07B | $10.79B | (m) |
| 2022-03-31 | (m) | $20.03B | $10.86B | (m) |
| 2021-12-31 | (m) | $19.93B | $10.81B | (m) |
| 2021-09-30 | (m) | $20.25B | $10.82B | (m) |
| 2021-06-30 | (m) | $19.90B | $10.55B | (m) |
| 2021-03-31 | (m) | $18.86B | $10.02B | (m) |
| 2020-12-31 | (m) | $18.21B | $9.88B | (m) |
| 2020-09-30 | $7.58B | $17.12B | $9.54B | 44.27% |
| 2020-06-30 | (m) | $16.92B | $9.28B | (m) |
| 2020-03-31 | (m) | $17.41B | $9.36B | (m) |
| 2019-12-31 | (m) | $17.36B | $9.06B | (m) |
| 2019-09-30 | $8.29B | $17.29B | $9.00B | 47.94% |
| 2019-06-30 | (m) | $17.11B | $9.00B | (m) |
| 2019-03-31 | (m) | $17.04B | $8.99B | (m) |
| 2018-12-31 | (m) | $17.06B | $9.38B | (m) |
| 2018-09-30 | $7.26B | $15.98B | $8.72B | 45.44% |
| 2018-06-30 | (m) | $14.75B | $8.02B | (m) |
| 2018-03-31 | (m) | $13.50B | $7.29B | (m) |
| 2017-12-31 | (m) | $12.25B | $6.21B | (m) |
| 2017-09-30 | $5.94B | $12.09B | $6.15B | 49.14% |
| 2017-06-30 | (m) | $12.16B | $6.22B | (m) |
| 2017-03-31 | (m) | $12.32B | $6.34B | (m) |
| 2016-12-31 | (m) | $12.42B | $6.38B | (m) |
| 2016-09-30 | $5.99B | $12.48B | $6.49B | 47.99% |
| 2016-06-30 | (m) | $12.31B | $6.44B | (m) |
| 2016-03-31 | (m) | $12.23B | $6.74B | (m) |
| 2015-12-31 | (m) | $11.22B | $6.16B | (m) |
| 2015-09-30 | $4.70B | $10.28B | $5.59B | 45.66% |
| 2015-06-30 | (m) | $9.42B | $5.04B | (m) |
| 2015-03-31 | (m) | $8.46B | $4.16B | (m) |
| 2014-12-31 | (m) | $8.48B | $4.17B | (m) |
| 2014-09-30 | (m) | $8.45B | $4.14B | (m) |
| 2014-06-30 | (m) | $8.35B | $4.06B | (m) |
| 2014-03-31 | (m) | $8.24B | $4.01B | (m) |
| 2013-12-31 | (m) | $8.17B | $3.97B | (m) |
| 2013-09-30 | (m) | $8.05B | $3.88B | (m) |
| 2013-06-30 | (m) | $7.92B | $3.84B | (m) |
| 2013-03-31 | (m) | $7.85B | $3.79B | (m) |
| 2012-12-31 | (m) | $7.78B | $3.75B | (m) |
| 2012-09-30 | (m) | $7.71B | $3.76B | (m) |
| 2012-06-30 | (m) | $7.97B | $3.87B | (m) |
| 2012-03-31 | (m) | $7.94B | $3.85B | (m) |
| 2011-12-31 | (m) | $7.87B | $3.80B | (m) |
| 2011-09-30 | (m) | $7.83B | $3.74B | (m) |
| 2011-06-30 | (m) | $7.65B | $3.64B | (m) |
| 2011-03-31 | (m) | $7.47B | $3.57B | (m) |
| 2010-12-31 | (m) | $7.35B | $3.51B | (m) |
| 2010-09-30 | (m) | $7.37B | $3.54B | (m) |
| 2010-06-30 | (m) | $7.54B | $3.62B | (m) |
| 2010-03-31 | (m) | $7.48B | $3.58B | (m) |
| 2009-12-31 | (m) | $7.36B | $3.52B | (m) |
| 2009-09-30 | (m) | $7.16B | $3.40B | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | $7.07B | $3.45B | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) |
| 2007-09-30 | (m) | $6.28B | $3.03B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |